BR0010618A - Sistema terapêutico transdermal (tts), que contém tolterodina - Google Patents

Sistema terapêutico transdermal (tts), que contém tolterodina

Info

Publication number
BR0010618A
BR0010618A BR0010618-6A BR0010618A BR0010618A BR 0010618 A BR0010618 A BR 0010618A BR 0010618 A BR0010618 A BR 0010618A BR 0010618 A BR0010618 A BR 0010618A
Authority
BR
Brazil
Prior art keywords
tts
therapeutic system
transdermal therapeutic
tolterodine
containing tolterodine
Prior art date
Application number
BR0010618-6A
Other languages
English (en)
Inventor
Christoph Arth
Claus Meese
Dietrich Wilhelm Schacht
Hans-Michael Wolff
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of BR0010618A publication Critical patent/BR0010618A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "SISTEMA TERAPêUTICO TRANSDERMAL (TTS), QUE CONTéM TOLTERODINA". A invenção refere-se a um sistema terapêutico transdermal (TTS) para a administração transcutânea de tolterodina por vários dias, bem como a um processo para produção do mesmo. O TTS contém uma massa de matriz em forma de camadas, auto-adesiva, que contém um copolímero de (met)acrilato, que contém grupos amónio, pelo menos um emoliente e até 25% em peso de tolterodina.
BR0010618-6A 1999-05-18 2000-05-16 Sistema terapêutico transdermal (tts), que contém tolterodina BR0010618A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19922662A DE19922662C1 (de) 1999-05-18 1999-05-18 Transdermales therapeutisches System (TTS) Tolterodin enthaltend
PCT/EP2000/004360 WO2000069421A2 (de) 1999-05-18 2000-05-16 Transdermales therapeutisches system (tts) tolterodin enthaltend

Publications (1)

Publication Number Publication Date
BR0010618A true BR0010618A (pt) 2002-02-19

Family

ID=7908327

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010618-6A BR0010618A (pt) 1999-05-18 2000-05-16 Sistema terapêutico transdermal (tts), que contém tolterodina

Country Status (19)

Country Link
US (1) US6783769B1 (pt)
EP (1) EP1178782B1 (pt)
JP (1) JP2002544222A (pt)
CN (1) CN1356894A (pt)
AT (1) ATE335469T1 (pt)
AU (1) AU772648B2 (pt)
BR (1) BR0010618A (pt)
CA (1) CA2373629A1 (pt)
DE (2) DE19922662C1 (pt)
DK (1) DK1178782T3 (pt)
ES (1) ES2270832T3 (pt)
HK (1) HK1047703A1 (pt)
MX (1) MXPA01011536A (pt)
NO (1) NO20015614D0 (pt)
PL (1) PL352057A1 (pt)
PT (1) PT1178782E (pt)
RU (1) RU2251413C2 (pt)
WO (1) WO2000069421A2 (pt)
ZA (1) ZA200108147B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19932651A1 (de) * 1999-07-13 2001-01-18 Hexal Ag Transdermales therapeutisches System zur Anwendung von Tolterodin
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
AU2002316053A1 (en) 2001-05-01 2002-11-11 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
WO2002087645A1 (en) 2001-05-01 2002-11-07 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2005074894A1 (en) 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
MX2007001512A (es) 2004-08-05 2007-04-20 Corium Int Inc Composicion adhesiva.
CN1795845B (zh) * 2004-12-23 2010-10-13 李又欣 作为毒蕈碱受体拮抗剂的3,3-二苯基丙胺衍生物注射用缓释微球制剂
EP1836156A1 (en) * 2005-01-10 2007-09-26 Teva Gyogyszergyar Reszvenytarsasag Substantially pure tolterodine tartrate and process for preparing thereof
CA2596529C (en) * 2005-01-27 2014-08-19 Corium International, Inc. Hydrophilic biocompatible adhesive formulations and uses
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
WO2009126844A2 (en) * 2008-04-09 2009-10-15 Concert Pharmaceuticals Inc. Derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
CA2751884C (en) 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
KR20110001103A (ko) * 2009-06-29 2011-01-06 에스케이케미칼주식회사 보관 안정성이 향상된 톨테로딘 함유 경피 투여 조성물
KR101746204B1 (ko) 2010-02-18 2017-06-13 에스케이케미칼주식회사 피부 투과가 개선된 톨테로딘의 경피 투여용 조성물
EP2552486B1 (en) * 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
JP2012051875A (ja) * 2010-08-03 2012-03-15 Hisamitsu Pharmaceut Co Inc 経皮・経粘膜吸収製剤の保存方法及び経皮・経粘膜吸収製剤包装体
WO2012017892A1 (ja) 2010-08-03 2012-02-09 久光製薬株式会社 貼付剤及びその粘着力増強方法
TW201338813A (zh) 2011-12-12 2013-10-01 洛曼治療系統股份有限公司 經皮遞送系統
JP6087839B2 (ja) 2011-12-27 2017-03-01 帝國製薬株式会社 トルテロジン含有貼付剤
WO2014195352A1 (en) 2013-06-04 2014-12-11 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209605B (en) * 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JP3739806B2 (ja) * 1993-05-26 2006-01-25 埼玉第一製薬株式会社 骨格筋弛緩経皮吸収剤
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
JP2000515525A (ja) * 1996-07-19 2000-11-21 アベーグ,グンナー 尿と胃腸の疾患の治療におけるs(―)―トルテロジン
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
SK287111B6 (sk) * 1998-08-27 2009-12-07 Pharmacia & Upjohn Ab Farmaceutický prípravok obsahujúci tolterodin s regulovaným uvoľňovaním
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder

Also Published As

Publication number Publication date
JP2002544222A (ja) 2002-12-24
DE19922662C1 (de) 2000-12-28
CN1356894A (zh) 2002-07-03
MXPA01011536A (es) 2003-09-10
WO2000069421A3 (de) 2001-03-22
EP1178782B1 (de) 2006-08-09
AU772648B2 (en) 2004-05-06
ES2270832T3 (es) 2007-04-16
PL352057A1 (en) 2003-07-28
RU2251413C2 (ru) 2005-05-10
CA2373629A1 (en) 2000-11-23
PT1178782E (pt) 2006-12-29
DK1178782T3 (da) 2006-12-11
AU4921800A (en) 2000-12-05
EP1178782A2 (de) 2002-02-13
WO2000069421A2 (de) 2000-11-23
NO20015614L (no) 2001-11-16
ZA200108147B (en) 2002-06-27
ATE335469T1 (de) 2006-09-15
HK1047703A1 (zh) 2003-03-07
US6783769B1 (en) 2004-08-31
NO20015614D0 (no) 2001-11-16
DE50013305D1 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
BR0010618A (pt) Sistema terapêutico transdermal (tts), que contém tolterodina
PT1077688E (pt) Sistema terapeutico transdermico contendo pergolide
PT1063983E (pt) Sistema terapeutico transdermico (tts) contendo oxibutinina
DK0764020T3 (da) Transdermalt system til indgivelse af lægemiddel
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
NZ306249A (en) matrix patch containing triacetin as a transdermal pentration enhancer
DE69909777D1 (de) Haftende Mikrokügelchen umfassende Zusammensetzung zur Arzneimittelgabe
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
ATE395050T1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
FI971711A0 (fi) Levobupivakaiinin ja sen analogien kiteyttäminen
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel
MX2022009114A (es) Sistema terapeutico transdermico que comprende el ingrediente rotigotina y al menos un adhesivo de silicona no resistente a mina.
IT1297139B1 (it) Composizioni per la somministrazione transdermica e dermica di sostanze biologicamente attive
WO2001070224A3 (fr) Pansement a base de rilmenidine et son procede de preparation

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.